Stock screener

TELO

Conviction 0HealthcareScan · Mon, Aug 10, 2026
Bearish marubozu
TELO$1.16-0.85%
ResistanceSupportVol 14
63 bars
Vol MA14 96.25K
May 8May 27Jun 15Jul 2Jul 22Aug 7
Telomir Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.telomirpharma.com ↗
Price1.16
Change-0.85%
Gap+0.00%
Rel volume0.11×
Avg volume104.07K
Avg $ vol116.4K
SMA 201.17
SMA 501.22
SMA 2001.30
Price vs 50-5.21%
Price vs 200-10.98%
MA stackbearish
50/200 cross—
Supertrendup · 0.9419
RSI (14)47
MACD hist0.00
MACD crossbull · 9d
Stoch %K / %D74 / 77
ADX (14)15
+DI / −DI16 / 24
RSI divergence—
MACD divergence—
ATR %+7.03%
ADR %8.04%
52w high1.93
52w low0.9192
From 52w high-39.90%
Above 52w low+26.20%
New 52w highNo
SqueezeOff
Bollinger width26.29%
%B0.48
Donchian pos75.11%
Donchian high1.25
Donchian low0.8884
AVWAP (52w high)1.57
vs AVWAP high-26.14%
AVWAP (52w low)1.11
vs AVWAP low+4.89%
OBV trendDown
Chaikin MF (20)-0.03
Today vs 20d0.11×
Avg vol (14d)96.25K
Avg vol (20d)104.07K
Avg $ vol (20d)116.4K
Market cap79.78M
RS 3m (vs SPY)-17.82%
RS 6m (vs SPY)-10.54%
RS line new highNo
Trend template0/8
Technical rank29.7
1 week-4.13%
1 month-8.66%
3 months-12.12%
6 months+3.57%
1 year-36.96%
YTD-13.43%
P/E-7.66
P/B16.08
P/S—
P/FCF—
EPS-0.3300
Div yield—
ROE-209.85%
ROA-179.86%
Debt/Eq—
Current7.00
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth37.01%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value79.02M
Revenue—
Net income-990.95K
Gross profit—
Free cash flow—
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out68.77M
Employees5
ListedFri, Feb 9, 2024
Free float11.25M
Float %32.7%
Short interest974.29K
Days to cover18.4d
Short volume41.5%
Squeeze score43 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank29.7 / 100
Group rank86 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBearish marubozu
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TELO

All disclosures →
No recent disclosed trades by Congress in TELO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TELO · 8 buys · 2 sells

InsiderSideShares
Whalen Matthew Pratt
Director · Non-Qualified Stock Options (right to buy) · 2026-04-16
Grant50K
Del Giudice Matthew Paul
Director · Non-Qualified Stock Options (right to buy) · 2026-04-16
Grant50K
MacPherson Edward Clouston
Director · Non-Qualified Stock Options (right to buy) · 2026-04-16
Grant50K
MacPherson Edward Clouston
Director · Incentive Stock Options (right to buy) · 2026-05-21
Disposition25K
Whalen Matthew Pratt
Director · Incentive Stock Options (right to buy) · 2026-05-21
Grant25K
MacPherson Edward Clouston
Director · Incentive Stock Options (right to buy) · 2026-05-21
Grant25K
Aminov Erez
CEO and Chairman · Non-Qualified Stock Options (right to buy) · 2026-05-21
Disposition2M
Aminov Erez
CEO and Chairman · Non-Qualified Stock Options (right to buy) · 2026-05-21
Grant2M
Aminov Erez
CEO and Chairman · Incentive Stock Options (right to buy) · 2026-05-21
Grant1.96M
Del Giudice Matthew Paul
Director · Incentive Stock Options (right to buy) · 2026-05-21
Grant25K

SEC filings

EDGAR filings in TELO · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.